abdominal aortic aneurysm; cost-effectiveness; follow-up; preventive medicine; screening program; ultrasound; Age Factors; Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal/diagnostic imaging; Aortic Aneurysm, Abdominal/economics; Aortic Aneurysm, Abdominal/mortality; Aortic Aneurysm, Abdominal/therapy; Aortic Rupture/diagnostic imaging; Aortic Rupture/economics; Aortic Rupture/mortality; Aortic Rupture/therapy; Cost-Benefit Analysis; Early Diagnosis; Female; Health Care Costs; Humans; Life Expectancy; Male; Mass Screening/economics; Mass Screening/methods; Middle Aged; Predictive Value of Tests; Prevalence; Prognosis; Risk Assessment; Risk Factors; Sex Factors; Ultrasonography/economics; Aortic Aneurysm, Abdominal; Aortic Rupture; Mass Screening; Ultrasonography; Cardiology and Cardiovascular Medicine
Abstract :
[en] In Europe, the prevalence of abdominal aortic aneurysms (AAAs) in the elderly population (≥65 year old) has declined in the past decades to <4%. Aneurysmal degeneration of the aorta is a serious and potentially life-threatening vascular disease. Abdominal aortic aneurysms typically develop subclinically and often only become symptomatic when complicated by impending rupture. Most AAAs are discovered incidentally while investigating for an unrelated pathology. Ruptured AAA is the tenth leading cause of death in Belgium (0.32% of all deaths in 2014). Health-care providers have emphasized the importance of early detection of AAA and elective repair when the rupture risk outweighs operative risk (usual diameter threshold of 55 mm). Routine AAA screening programs, consisting of a single abdominal ultrasonography at the age of 65 years, aim to reduce the number of AAA-related deaths. Does population-based ultrasound screening for AAA achieve its objective and is it cost-effective? This literature review tries to answer these challenging questions.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Sprynger, Muriel ; Université de Liège - ULiège > Département des sciences cliniques
Willems, Michel; 2 Service de Statistiques Belges ( stabel.fgov ), Brussels, Belgium
Van Damme, Hendrik; 1 Department of Cardiology-Angiology, University Hospital Liège, Liège, Belgium
Drieghe, Benny; 3 Department of Cardiology-Angiology, University Hospital Ghent, Ghent, Belgium
Wautrecht, J C; 4 Department of Vascular Diseases, University Hospital ULB Erasme, Brussels, Belgium
Moonen, Marie ; Université de Liège - ULiège > Département des sciences cliniques
Stather P, Dattani N, Bown M, Earnshaw J, Lees T. International variations in AAA screening. Eur J Vasc Endovasc Surg. 2013;45(3):231–4.
Wanhainen A, Hultgren R, Linné A,; Swedish Aneurysm Screening Study Group (SASS). Outcome of the Swedish nation-wide abdominal aneurysm screening program. Circulation. 2016;134(6):1141–8.
Davis M, Harris M, Earnshaw JJ. Implementation of the National Health Service Abdominal Aortic Aneurysm Screening Program in England. J Vasc Surg. 2013;57(5):1440–5.
LeFevre ML, Siu AL, Peters JJ,; US Preventive Services Task Force. Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161(4):281–90.
Lederle FA. Screening for abdominal aortic aneurysm in the USA. Scand J Surg. 2008;97(2):139–41.
Chaikof E, Dalman R, Eskandari M. The Society of Vascular Surgery Practice Guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67(1):2–77.
Erbel R, Aboyans V, Boileau C,; for the Task-Force for Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35:2873–926.
Hafez H, Druce PS, Ashton HA. Abdominal aortic aneurysm development in men following a “normal” aortic ultrasound scan. Eur J Vasc Endovasc Surg. 2008;36:553–8.
Lindholt JS, Sorensen J, Sogaard R, Henneberg EW. Long-term benefit and cost-effectiveness analysis of screening for abdominal aortic aneurysm from a randomized controlled trial. Br J Surg. 2010;97(6):826–34.
Ashton HA, Buxton MJ, Day NE.; Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002;360(9345):1531–9.
Norman PE, Jamrozik K, Lawrence-Brown MM. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ. 2004;329(7477):1259–65.
Wilminck AB, Forshaw M, Quick CR, Hubbard CS, Day NE. Accuracy of serial screening for abdominal aortic aneurysm by ultrasound. J Med Screen. 2002;9(3):125–7.
Wanhainen A. How to define an abdominal aortic aneurysm? Influence on epidemiology and clinical practice. Scand J Surg. 2008;97:105–09.
Lindholdt J, Søgaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomized controlled trial. Lancet. 2017;390(10109):2256–65.
Olivier-Williams C, Sweeting M, Turton G. Lessons learned about prevalence and growth-rates of abdominal aortic aneurysms from a 25-year ultrasound population screening programme. Br J Surg. 2018;105(1):6874.
Belgian Ministry of Public Health. Belgian statistics 2015. www.statbel.fgov.be. Accessed February 1, 2018.
Ashton H, Conto E, Duffy S, Jamrozik K, Lindholt J,; Collaborative Aneurysm Screening Study Group (CASS Group) (for Chichester Aneurysm Screening Group; Viborg Aneurysm Screening Study; Western Australian Abdominal Aortic Aneurysm Program; Multicentre Aneurysm Screening Study). A comparative study of the prevalence of abdominal aortic aneurysms in the United Kingdom, Denmark, and Australia. J Med Screen. 2001;8(1):46–50.
Guirguis-Blake J, Beil T, Senger C, Whitlock E. Ultrasonography screening for abdominal aortic aneurysm: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:321–9.
Blanchard JF. Epidemiology of abdominal aortic aneurysm. Epidemiol Rev. 1999;21(2):207–21.
Scott RA, Bridgewater SG, Ashton HA. Randomized clinical trial of screening for abdominal aortic aneurysm in women. Br J Surg. 2002;89(3):283–5.
Ali MU, Fitzpatrick-Lewis D, Miller J. Screening for abdominal aortic aneurysm in asymptomatic adults. J Vasc Surg. 2016;64(6):1855–68.
Meecham L, Jacomelli J, Pherwani AD, Earnshaw J. Self-referral to the NHS abdominal aortic aneurysm screening program. Eur J Vasc Surg. 2016;52:317–21.
Sandiford P, Mosquera D, Bramley D. Trends in incidence and mortality from abdominal aortic aneurysm in New Zealand. Br J Surg. 2011;98(5):645–51.
Lederle FA. The rise and fall of abdominal aortic aneurysm. Circulation. 2011;124(10):1097–9.
Lederle FA, Nelson DB, Joseph AM. Smokers’ relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J Vasc Surg. 2003;38(2):329–34.
Badger SA, O’Donnel ME, Sharif MA, McMaster C, Young IS, Soong CV. The role of smoking in AAA development. Angiology. 2009;60(1):115–9.
Van de Luijtgaarden K, Rouwet E, Hoeks S, Stolker R, Verhagen H, Majoor-Krakauer D. Risk of abdominal aortic aneurysm among male and female relatives of abdominal aortic aneurysm patients. Vasc Med. 2017;22(2):112–8.
Takagi H, Umemoto T. Diabetes and abdominal aortic aneurysm growth. Angiology. 2016; 67 (6):513–25.
Tsai C, Lin C, Wu Y, Shieh D, Sung F, Kao C. Advanced complicated diabetes mellitus is associated with a reduced risk of thoracic and abdominal aortic aneurysm rupture: a population-based cohort study. Diabetes Metab Res Rev. 2015;31(2):190–7.
De Rango P, Farchioni L, Fiorucci B, Lenti M. Diabetes and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2014;47:243–61.
Shah P. Inflammation, metalloproteinases and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation. 1997;96(7):2115–7.
Kotani K, Sahebkar A, Serban M. Lipoprotein(a) levels in patients with abdominal aortic aneurysm: a systematic review and meta-analysis. Angiology. 2017;68:99–108.
Leibundgut G, Scipione C, Yin H. Determinants of binding of oxidized phospholipids on apolipoprotein(a) and lipoprotein(a). J Lipid Res. 2013;54:2815–30.
Bos S, Yayha R, van Lennep J. Latest developments in the treatment of lipoprotein(a). Curr Opin Lipidol. 2014;25(6):452–60.
Takagi H, Yamamoto H, Iwata S, Goto T,; for the ALICE group. Effects of statin therapy on abdominal aortic aneurysm growth. A meta-analysis and meta-regression of observational comparative studies. Eur J Vasc Endovasc Surg. 2012;44(3):287–92.
Baxter B, Terrin M, Dalman P. Medical management of small abdominal aortic aneurysms. Circulation. 2008;117(14):1883–9.
Miyake T, Morishita R. Pharmacological treatment of abdominal aortic aneurysms. Cardiovasc Res. 2009;83:436–43.
Schouten O, van Laanen J, Boersma E. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg. 2006;32(1):21–6.
Ferguson C, Clancy P, Bourke B. Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J. 2010;159:307–13.
De Haro J, Acin F, Bleda S, Varela C, Medina FJ, Esparza L. Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of plasma levels of C-reactive protein levels. J Vasc Surg. 2012;56(1):45–52.
Earnshaw JJ, Shaw E, Whyman MR, Poskitt KR, Heather BP. Screening for abdominal aortic aneurysm in men. BMJ. 2004;328(7448):1122–4.
Crow P, Shaw E, Earnshaw JJ, Poskitt KR, Whyman MR, Heather BP. A single normal ultrasonographic scan at age 65 years rules out significant aneurysm disease for life in men. Br J Surg. 2001;88(7):941–4.
Thompson SG, Ashton HA, Gao L, Buxton MJ, Scott RA.,; Multicentre Aneurysm Screening Study (MASS) Group. Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening. Br J Surg. 2012; 99(12):1649–56.
Johansson M, Jorgensen K, Brodersen J. Harms of screening for abdominal aortic aneurysm: is there more to life than a 0.43% disease-specific mortality reduction? Lancet. 2016; 387 (10015):308–10.
Burges C, Cornelius V, Love S, Graham J, Richards M, Raminez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ. 2005;330:702.
Moll F, Powell J, Fraedrich G. Management of abdominal aortic aneurysms. Critical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg. 2011;41(suppl 1):S1–S58.
Lederle F, Johnson G, Wilson J. The aneurysm detection and management study screening program: validation cohort and final results (ADAM study). Arch Int Med. 2000; 160(10):1425–30.
Cao P, De Rango P, Parlani G, Romano L. Comparison of Surveillance versus Aortic Endografting for Small Aneurysm Repair (CAESAR): results from a randomised trial. Eur J Vasc Endovasc Surg. 2011; 41(1):13–25.
Ouriel K. The PIVOTAL study: a randomized comparison of endovascular repair versus surveillance in patients with smaller aortic aneurysms. J Vasc Surg. 2009;41(1):266–9.
Takagi H, Ando T, Umemoto T,; for the ALICE (All Literature Investigations of Cardiovascular Evidence) Group. Abdominal aortic aneurysm screening reduces all-cause mortality: make screening great again. Angiology. 2018;69(3):205–11.
Takagi H, Goto SN, Matsui M, Manabe H, Umemoto T. A further meta-analysis of population-based screening for abdominal aortic aneurysm. J Vasc Surg. 2010;52(4):1103–8.
Tran N, Quirsga E, Singh N. Preoperative risk score for the prediction of mortality following repair of ruptured abdominal aortic aneurysm. J Vasc Surg. 2015;61:6S–127S.
McCaul KA, Lawrence-Brown M, Dickinson J, Norman P. Long-term outcomes of the Western Australian trial of screening for abdominal aortic aneurysms. JAMA. 2016;176(12):1761–7.
Mastracci TM, Cinà CS,; Canadian Society for Vascular Surgery. Screening for abdominal aortic aneurysm in Canada: review and position statement of the Canadian Society for Vascular Surgery. J Vasc Surg. 2007;45(6):1268–76.
The US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26.
Lo R, Lu B, Fokkema M. Relative importance of aneurysm diameter and body size for predicting abdominal aortic aneurysm rupture in men and in women. J Vasc Surg. 2014;59(5):1209–16.
Bird AN, Davis A. Screening for abdominal aortic aneurysm. JAMA Clinical Guidelines Synopsis. JAMA. 2015;313(11):1156–7.
Norman P, Powell J. Abdominal aortic aneurysm: the prognosis in women is worse than in men. Circulation. 2007;115(22):2865–9.
Zarrouck M, Lundqvist A, Holst J, Troëng T, Gottsäter A. Cost-effectiveness of screening for abdominal aortic aneurysm in combination with medical intervention in patients with small aneurysms. Eur J Vasc Endovasc Surg. 2016;51(6):766–73.
Thompson SG, Ashton HA, Gao L, Scott RA.; Multicentre Aneurysm Screening Study Group. Screening men for abdominal aortic aneurysm: 10 year mortality and cost-effectiveness results from the randomised Multicentre Aneurysm Screening Study Group. BMJ. 2009;338:2307–11.
Kim LG, Thompson SG, Bfriggs AH, Buxton MJ, Campbell HE. How cost-effective is screening for abdominal aortic aneurysm? J Med Screen. 2007;14(1):46–52.
Hicks CW, Obeid T, Arhuidese I, Qazi U, Malas MB. AAA repair in octogenarians is associated with higher mortality compared with nonoctogenarians. J Vasc Surg. 2016;64(4):956–96.
Björck M, Bown M, Choke E,; for the International Abdominal Aortic Aneurysm Screening Group. International update on screening for abdominal aortic aneurysms: issues and opportunities. Eur J Vasc Endovasc Surg. 2015;49(2):113–5.
Earnshaw J, Lees T. Update on screening for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2017;54(1):1–2.
Spanos K, Labropoulos N, Giannoukas A. Abdominal aortic aneurysm screening: do we need to shift toward a targeted strategy? Angiology. 2018;69(3):192–4.
